THE EFFECT OF DONOR CYTOMEGALOVIRUS (CMV) SEROLOGIC STATUS ON CMV REACTIVATION AND SURVIVAL IN PATIENTS UNDERGOING ALLOGENIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Vega, J. [1 ]
Vatca, M. [1 ]
Mikulandric, N. [1 ]
Neme, K. [1 ]
Hanbali, A. [1 ]
Janakiraman, N. [1 ]
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.334
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
300
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [1] THE EFFECT OF DONOR CYTOMEGALOVIRUS (CMV) SEROLOGIC STATUS ON OUTCOME AND SURVIVAL IN PATIENTS UNDERGOING ALLOGENIC STEM CELL TRANSPLANTATION IN THE ERA OF CMV-PREEMPTIVE THERAPY
    Koh, L. P.
    Tay, P. F.
    Poon, M. L. M.
    Hwang, W. Y. K.
    Loh, Y. S. M.
    Tan, L. K.
    Goh, Y. T.
    Tan, B.
    Lee, J. J.
    Zhang, X. H.
    Lee, Y. M.
    Ng, H. Y.
    Linn, Y. C.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S280 - S281
  • [2] Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
    Huang, Yao-Ting
    Foldi, Julia
    Xiao, Kun
    Chung, Dick
    Neofytos, Dionysios
    Kolitsopoulos, Yovanna
    Maloy, Molly
    Giralt, Sergio
    Papadopoulos, Esperanza
    Jakubowski, Ann A.
    Papanicolaou, Genovefa
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S302 - S303
  • [3] Effect of the donor CMV status on CMV reactivation after allogeneic transplantation
    Nürnberger, W
    Krempe, C
    Steinhagen, G
    Adams, O
    Göbel, U
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S66 - S66
  • [4] Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients
    Pietersma, Floor L.
    van Dorp, Suzanne
    Minnema, Monique C.
    Kuball, Jurgen
    Meijer, Ellen
    Schuurman, Rob
    van Baarle, Debbie
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : E144 - E148
  • [5] Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status
    Servais, S.
    Dumontier, N.
    Biard, L.
    Schnepf, N.
    Resche-Rigon, M.
    de Latour, R. Peffault
    Scieux, C.
    Robin, M.
    Meunier, M.
    Xhaard, A.
    de Fontbrune, F. Sicre
    Le Goff, J.
    Socie, G.
    Simon, F.
    Mazeron, M. -C.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (03) : 289.e1 - 289.e7
  • [6] CMV SPECIFIC IMMUNITY IS SIGNIFICANTLY INFLUENCED BY DONOR CMV SEROLOGICAL STATUS AND TREATMENT FOR GVHD FOLLOWING ALLOGENIC STEM CELL TRANSPLANTATION
    Tkacova, Vlasta
    Valkova, Veronika
    Luxova, Alena
    Marinov, Iuri
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 452 - 452
  • [7] Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megatile analysis
    Ljungman, P
    Brand, R
    Einsele, H
    Frassoni, F
    Niederwieser, D
    Cordonnier, C
    [J]. BLOOD, 2003, 102 (13) : 4255 - 4260
  • [8] Cytomegalovirus (CMV) infections in children undergoing hematopoetic stem cell transplantation
    Zaucha-Prazmo, A
    Wójcik, B
    Drabko, K
    Choma, M
    Kowalczyk, JR
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2005, 22 (04) : 271 - 276
  • [9] Cmv Reactivation After Allogenic Hematopoietic Stem Cell Transplantation - Single Center Experience
    Balint, Milena Todorovic
    Pantic, Nikola
    Jankovic, Marko
    Djunic, Irena
    Smiljanic, Mihailo
    Gunjak, Tara
    Jovanovic, Tanja
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 272 - 273
  • [10] Risk for CMV Reactivation in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Qayed, Muna
    Khurana, Monica
    Hilinski, Joseph
    Gillespie, Scott
    McCracken, Courtney
    Applegate, Kristy
    Chiang, Kuang-Yueh
    Horan, John
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 364 - 366
12345